IFPMA invites Indian and Chinese firms to swine flu vaccine talks
This article was originally published in Scrip
Executive Summary
The international pharmaceutical industry association IFPMA, which represents multinational drug firms, invited Indian and Chinese firms to be involved in discussions with the World Health Organization on manufacturing a potential swine influenza A (H1N1) vaccine earlier this week.